[HTML][HTML] Recent advances in therapeutic applications of neutralizing antibodies for virus infections: an overview
Antibodies are considered as an excellent foundation to neutralize pathogens and as highly
specific therapeutic agents. Antibodies are generated in response to a vaccine but little use …
specific therapeutic agents. Antibodies are generated in response to a vaccine but little use …
[HTML][HTML] Improving the efficacy of regulatory T cell therapy
P Baeten, L Van Zeebroeck, M Kleinewietfeld… - Clinical reviews in …, 2022 - Springer
Autoimmunity is caused by an unbalanced immune system, giving rise to a variety of organ-
specific to system disorders. Patients with autoimmune diseases are commonly treated with …
specific to system disorders. Patients with autoimmune diseases are commonly treated with …
[HTML][HTML] Crosstalk between nucleocytoplasmic trafficking and the innate immune response to viral infection
The nuclear pore complex is the sole gateway connecting the nucleoplasm and cytoplasm.
In humans, the nuclear pore complex is one of the largest multiprotein assemblies in the cell …
In humans, the nuclear pore complex is one of the largest multiprotein assemblies in the cell …
[HTML][HTML] Immunesenescence: a predisposing risk factor for the development of COVID-19?
J Hazeldine, JM Lord - Frontiers in immunology, 2020 - frontiersin.org
Bearing a strong resemblance to the phenotypic and functional remodeling of the immune
system that occurs during aging (termed immunesenescence), the immune response to …
system that occurs during aging (termed immunesenescence), the immune response to …
SARS-CoV-2/COVID-19: evolving reality, global response, knowledge gaps, and opportunities
Approximately 3 billion people around the world have gone into some form of social
separation to mitigate the current severe acute respiratory syndrome coronavirus 2 (SARS …
separation to mitigate the current severe acute respiratory syndrome coronavirus 2 (SARS …
Evaluating fluvoxamine for the outpatient treatment of COVID‐19: A systematic review and meta‐analysis
This systematic review and meta‐analysis of randomised controlled trials (RCTs) aimed to
evaluate the efficacy, safety, and tolerability of fluvoxamine for the outpatient management of …
evaluate the efficacy, safety, and tolerability of fluvoxamine for the outpatient management of …
[HTML][HTML] Neutrophil-to-lymphocyte ratios are closely associated with the severity and course of non-mild COVID-19
S Qun, Y Wang, J Chen, X Huang, H Guo, Z Lu… - Frontiers in …, 2020 - frontiersin.org
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is
spreading worldwide. Measuring the prevention and control of the disease has become a …
spreading worldwide. Measuring the prevention and control of the disease has become a …
SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation …
TC Dakal - Immunobiology, 2021 - Elsevier
SARS-CoV-2 is a highly contagious virus that has caused serious health crisis world-wide
resulting into a pandemic situation. As per the literature, the SARS-CoV-2 is known to exploit …
resulting into a pandemic situation. As per the literature, the SARS-CoV-2 is known to exploit …
COVID‐19 immunopathology with emphasis on Th17 response and cell‐based immunomodulation therapy: potential targets and challenges
A Pourgholaminejad… - Scandinavian Journal …, 2022 - Wiley Online Library
The role of the immune system against coronavirus disease 2019 (COVID‐19) is unknown in
many aspects, and the protective or pathologic mechanisms of the immune response are …
many aspects, and the protective or pathologic mechanisms of the immune response are …
[HTML][HTML] A Randomized, Single-blind, Group sequential, Active-controlled Study to evaluate the clinical efficacy and safety of α-Lipoic acid for critically ill patients with …
M Zhong, A Sun, T Xiao, G Yao, L Sang, X Zheng… - Frontiers in …, 2022 - frontiersin.org
Object To evaluate the clinical efficacy and safety of α-Lipoic acid (ALA) for critically ill
patients with coronavirus disease 2019 (COVID-19). Methods A randomized, single-blind …
patients with coronavirus disease 2019 (COVID-19). Methods A randomized, single-blind …